Item 7.01. Regulation FD Disclosure.

Eloxx Pharmaceuticals, Inc. (the "Company") will be presenting at H.C. Wainwright's 23rd Annual Global Investment Conference, which is being held from September 13, 2021 through September 15, 2021. A copy of the Company's presentation materials that will be used at the conference is available through the "Events & Presentations" page of the Company's website at https://investors.eloxxpharma.com/events-and-presentations.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

© Edgar Online, source Glimpses